164 related articles for article (PubMed ID: 4820944)
1. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
Halliday WJ; Maluish A; Isbister WH
Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
[TBL] [Abstract][Full Text] [Related]
2. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
Grosser N; Thompson DM
Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
Halliday WJ; Maluish AE; Little JH; Davis NC
Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
[TBL] [Abstract][Full Text] [Related]
4. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
Maluish A; Halliday WJ
J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
[No Abstract] [Full Text] [Related]
6. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
8. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
10. Effect of surgery on tumour-directed leucocyte responses.
Vose BM; Moudgil GC
Br Med J; 1975 Jan; 1(5949):56-8. PubMed ID: 1109658
[TBL] [Abstract][Full Text] [Related]
11. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
Marti JH; Grosser N; Thomson DM
Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
[TBL] [Abstract][Full Text] [Related]
12. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Marti JH; Thomson DM
Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
[TBL] [Abstract][Full Text] [Related]
14. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
Winter M; Nelson DS; Milton GW
Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition.
Ablin RJ; Bhatti RA; Guinan PD; Bruns GR
Urol Int; 1976; 31(6):459-69. PubMed ID: 795128
[TBL] [Abstract][Full Text] [Related]
16. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
17. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
18. Early onset of serum blocking in a murine melanoma model.
Bray AE; Holt PG; Roberts LM; Keast D
Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
[TBL] [Abstract][Full Text] [Related]
19. Automated leucocyte adherence inhibition testing in patients with colorectal cancer.
McLeod DK; Isbister WH
Immunol Cell Biol; 1987 Oct; 65 Pt 5():377-85. PubMed ID: 3325409
[TBL] [Abstract][Full Text] [Related]
20. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
